Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
0.7478
+0.0223 (3.07%)
At close: Sep 17, 2026, 4:00 PM EDT
0.7623
+0.0145 (1.94%)
After-hours: Sep 17, 2026, 7:22 PM EDT
Daré Bioscience Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
| 1.37 | 1.16 | 1.03 | -0.06 | -0.02 | 0.03 | 0.01 | 1.88 | 2.84 | 2.82 | 2.81 | 1 | - | 10 | 10 | 10 | 10 | - | - | - | |
Revenue Growth (YoY) | - | 4366.48% | 10429.36% | - | - | -99.08% | -99.65% | 88.13% | - | -71.83% | -71.92% | -90.00% | - | - | - | - | - | - | - | - |
Cost of Revenue | -1.97 | -1.1 | 0.3 | -6.08 | 3.72 | -1.06 | - | 32.54 | 21.6 | 24.97 | 21.64 | 30.14 | 30.14 | 30.14 | 30.14 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
Gross Profit | 3.33 | 2.26 | 0.73 | 6.02 | -3.74 | 1.09 | 0.01 | -30.66 | -18.76 | -22.16 | -18.83 | -29.14 | -30.14 | -20.14 | -20.14 | 9.9 | 9.9 | -0.1 | -0.1 | -0.1 |
Selling, General & Admin | 8.92 | 8.7 | 8.76 | 9.18 | 8.72 | 8.79 | 9.16 | 10.11 | 10.77 | 11.24 | 11.91 | 12.18 | 12.14 | 12.01 | 11.24 | 10.42 | 9.98 | 8.98 | 8.35 | 7.73 |
Research & Development | 5.52 | 5.52 | 5.52 | 14.31 | 6.02 | 14.31 | 14.31 | -17.74 | -2.78 | -5.02 | - | 0.67 | -1.54 | -0.79 | - | 24.18 | 30.15 | 30.69 | 30.62 | 30.14 |
Operating Expenses | 14.44 | 14.23 | 14.29 | 23.49 | 14.74 | 23.1 | 23.46 | -7.62 | 7.99 | 6.22 | 11.91 | 12.86 | 10.6 | 11.23 | 11.24 | 34.6 | 40.13 | 39.68 | 38.97 | 37.87 |
Operating Income | -11.11 | -11.97 | -13.55 | -17.47 | -18.48 | -22.01 | -23.45 | -23.03 | -26.75 | -28.38 | -30.74 | -42 | -40.74 | -31.37 | -31.39 | -24.7 | -30.23 | -39.78 | -39.07 | -37.97 |
Other Non Operating Income (Expenses) | 0.12 | -0.05 | 0.15 | 0.01 | -0.13 | 20.93 | 20 | 20.23 | 20.35 | -0.29 | 0.78 | 0.95 | 0.97 | 0.78 | 0.44 | 0.15 | 0.03 | 0 | 0 | 0 |
EBT Excluding Unusual Items | -10.99 | -12.02 | -13.4 | -17.46 | -18.6 | -1.08 | -3.45 | -2.8 | -6.4 | -28.67 | -29.96 | -41.05 | -39.77 | -30.59 | -30.95 | -24.55 | -30.19 | -39.77 | -39.07 | -37.97 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | -0.6 | -0.6 | -0.6 | -0.6 | - | - | - | - | - | - | - | - | - | - | - |
Other Unusual Items | - | - | - | - | - | - | - | -0.4 | -0.4 | -0.4 | -0.4 | - | - | - | - | - | - | - | 0.37 | 0.37 |
Pretax Income | -10.99 | -12.02 | -13.4 | -17.46 | -18.6 | -1.68 | -4.05 | -3.6 | -7.2 | -28.87 | -30.16 | -41.05 | -39.77 | -30.59 | -30.95 | -24.55 | -30.19 | -39.77 | -38.7 | -37.6 |
Net Income | -10.99 | -12.02 | -13.4 | -17.46 | -18.6 | -1.68 | -4.05 | -3.6 | -7.2 | -28.87 | -30.16 | -41.05 | -39.77 | -30.59 | -30.95 | -24.55 | -30.19 | -39.77 | -38.7 | -37.6 |
Net Income to Common | -10.99 | -12.02 | -13.4 | -17.46 | -18.6 | -1.68 | -4.05 | -3.6 | -7.2 | -28.87 | -30.16 | -41.05 | -39.77 | -30.59 | -30.95 | -24.55 | -30.19 | -39.77 | -38.7 | -37.6 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 14 | 13 | 11 | 10 | 9 | 9 | 8 | 8 | 8 | 8 | 7 | 7 | 7 | 7 | 7 | 6 | 7 | 6 | 5 | 5 |
Shares Outstanding (Diluted) | 14 | 13 | 11 | 10 | 9 | 9 | 8 | 8 | 8 | 8 | 7 | 7 | 7 | 7 | 7 | 6 | 7 | 6 | 5 | 5 |
Shares Change (YoY) | 62.78% | 46.86% | 31.55% | 15.45% | 10.12% | 13.25% | 16.80% | 16.29% | 10.31% | 7.17% | 3.23% | 11.21% | 7.48% | 19.65% | 38.29% | 33.74% | 93.54% | 101.36% | 103.23% | 130.37% |
EPS (Basic) | -0.78 | -0.95 | -1.20 | -1.82 | -2.14 | -0.20 | -0.48 | -0.43 | -0.91 | -3.81 | -4.15 | -5.74 | -5.57 | -4.32 | -4.39 | -3.82 | -4.54 | -6.72 | -7.59 | -7.82 |
EPS (Diluted) | -0.78 | -0.95 | -1.20 | -1.82 | -2.14 | -0.20 | -0.48 | -0.43 | -0.91 | -3.81 | -4.15 | -5.74 | -5.57 | -4.32 | -4.39 | -3.82 | -4.60 | -6.72 | -7.59 | -7.82 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Free Cash Flow | -11.76 | -10.16 | -10.27 | -6.77 | -11.79 | 6.09 | 4.9 | -8.63 | -10.98 | -30.19 | -39.49 | -36.6 | -20.06 | -21.92 | -18.15 | -22.17 | -29.41 | -32.75 | -28.78 | -28.06 |
Free Cash Flow Per Share | -0.83 | -0.81 | -0.92 | -0.70 | -1.36 | 0.71 | 0.58 | -1.04 | -1.39 | -3.98 | -5.43 | -5.12 | -2.81 | -3.10 | -2.58 | -3.45 | -4.42 | -5.53 | -5.65 | -5.83 |
Gross Margin | 243.91% | 194.95% | 71.29% | - | - | 4205.96% | 100.00% | - | - | - | - | - | - | -201.42% | -201.42% | 99.00% | 99.00% | - | - | - |
Operating Margin | -813.38% | -1034.38% | -1315.51% | - | - | -84951.68% | -239692.20% | -1224.39% | -942.02% | -1007.38% | -1094.77% | -4199.90% | - | -313.68% | -313.86% | -246.98% | -302.28% | - | - | - |
Profit Margin | -804.37% | -1038.77% | -1300.66% | - | - | -6470.92% | -41430.90% | -191.61% | -253.60% | -1024.93% | -1074.17% | -4104.70% | - | -305.92% | -309.48% | -245.47% | -301.94% | - | - | - |
Free Cash Flow Margin | -860.62% | -878.30% | -997.01% | - | - | 23516.51% | 50086.97% | -458.66% | -386.77% | -1071.59% | -1406.26% | -3659.92% | - | -219.21% | -181.52% | -221.68% | -294.07% | - | - | - |
EBITDA | -8.98 | -9.96 | -11.92 | -16.35 | -17.83 | -21.8 | -23.41 | -22.99 | -26.7 | -28.34 | -30.7 | -41.96 | -40.71 | -31.34 | -31.36 | -24.68 | -30.2 | -39.75 | -39.04 | -37.94 |
EBITDA Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -246.77% | - | - | - | - |
D&A For EBITDA | 2.13 | 2.01 | 1.63 | 1.12 | 0.65 | 0.21 | 0.04 | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 |
EBIT | -11.11 | -11.97 | -13.55 | -17.47 | -18.48 | -22.01 | -23.45 | -23.03 | -26.75 | -28.38 | -30.74 | -42 | -40.74 | -31.37 | -31.39 | -24.7 | -30.23 | -39.78 | -39.07 | -37.97 |
EBIT Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -246.98% | - | - | - | - |
Revenue as Reported | 1.37 | 1.16 | 1.03 | - | - | 0.03 | 0.01 | 1.88 | 2.84 | 2.82 | 2.81 | 1 | - | 10 | 10 | 10 | 10 | - | - | - |